文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

胎盘植入剖宫产麻醉管理:联合与不联合腹主动脉球囊阻断的随机对照试验研究方案

Anesthetic management of cesarean section in cases of placenta accreta, with versus without abdominal aortic balloon occlusion: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-05-26

本研究为研究者发起的随机对照试验,计划纳入170例胎盘植入剖宫产产妇,随机分为腹主动脉球囊阻断联合剖宫产组与传统剖宫产后子宫切除术组,主要结局为估计失血量,旨在验证腹主动脉球囊阻断技术的优越性。

要点

  • 胎盘植入与大量出血相关,威胁母婴生命,剖宫产率上升使其发病率显著增加。
  • 目前腹主动脉球囊阻断相关研究几乎均为回顾性,证据不足以推荐或不推荐常规使用。
  • 本试验拟随机比较腹主动脉球囊阻断联合剖宫产与传统剖宫产后子宫切除术的优劣。

核心结论

  • 本前瞻性试验将检验腹主动脉球囊阻断联合剖宫产相较于传统剖宫产后子宫切除术对胎盘植入产妇的优越性。
  • 该试验可能为腹主动脉球囊阻断联合剖宫产用于胎盘植入产妇的获益与风险提供有力证据。

研究设计与样本

  • 研究者发起的、前瞻性随机对照试验,检验腹主动脉球囊阻断联合剖宫产相较于传统剖宫产后子宫切除术的优越性。
  • 计划纳入170例接受剖宫产的胎盘植入产妇,随机分配至腹主动脉球囊阻断联合剖宫产组或传统剖宫产后子宫切除术组。
  • 试验注册于中国临床试验注册中心,注册号ChiCTR-INR-16008842,注册日期2016年7月14日。

主要发现

  • 主要结局为估计失血量。
  • 最重要的次要结局为分娩期间剖宫产子宫切除术的发生;其他次要结局包括输血量、手术时间、新生儿Apgar评分(于1、5、10分钟采集)、重症监护病房住院时长、总住院时长及球囊阻断相关数据。

局限性

  • 截至目前,关于腹主动脉球囊阻断的研究几乎均为回顾性研究。
  • 当前证据不足以推荐或不推荐常规使用腹主动脉球囊阻断技术控制胎盘植入患者术中出血。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Placenta accreta (PA), a severe complication during delivery, is closely linked with massive hemorrhage which could endanger the lives of both mother and baby. Moreover, the incidence of PA has increased dramatically with the increasing rate of cesarean deliveries in the past few decades. Therefore, studies evaluating the effects of different perioperative managements based on different modalities in the treatment of PA are necessary. Among the numerous treatment measures, prophylactic abdominal aortic balloon occlusion (AABO) in combination with cesarean section for PA seems to be more advantageous than others. However, up to now, all studies on AABO were almost retrospective. Current evidence is insufficient to recommend for or against routinely using the AABO technology for control intraoperative hemorrhage in patients with PA. Thus, we hope to carry out a prospective, randomized controlled trial (RCT) study to confirm the effectiveness of the AABO technology in patients with PA. METHODS/DESIGN: This trial is an investigator-initiated, prospective RCT that will test the superiority of AABO in combination with cesarean section compared to the traditional hysterectomy following cesarean section for parturients with PA. A total of 170 parturients with PA undergoing cesarean section will be randomized to receive either AABO in combination with cesarean section or the traditional hysterectomy following cesarean section. The primary outcome is estimated blood loss. The most important secondary outcome is the occurrence of cesarean hysterectomy during delivery; others include blood transfusion volume, operating time, neonate's Apgar scores (collected at 1, 5 and 10 min), length of stay in intensive care unit, total hospital stay, and balloon occlusion-relative data. DISCUSSION: This prospective trial will test the superiority of AABO in combination with cesarean section compared to the traditional hysterectomy following cesarean section for parturients with PA. It may provide strong evidence about the benefits and risks of AABO in combination with cesarean section for parturients with PA. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR-INR-16008842 . Registered on 14 July 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chu Q, Shen D, He L, et al. Anesthetic management of cesarean section in cases of placenta accreta, with versus without abdominal aortic balloon occlusion: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28549439. doi:10.1186/s13063-017-1977-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。